MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Coexisting CACNA1A pathogenic variant and MJD expansion in the same family

    L. Leitão, C. Figueiredo, M. Santos, A.F. Brandão, A. Lopes, J. Sequeiros, I. Alonso, C. Costa (Amadora, Portugal)

    Objective: Genetic investigation of a family with inherited cerebellar ataxia. Background: Despite the identification of an increasing number of genes causing dominant spinocerebellar ataxias (SCAs),…
  • 2018 International Congress

    Vestibulo-Ocular Reflex Assessment in Patients with Sporadic Ataxia

    H. Teive, B. Zeigelboim, K. Kronbauer, A. Vom Scheidt, R. Santos, N. Mello (Curitiba, Brazil)

    Objective: To identify vestibular alterations in patients with sporadic ataxia (SA). Background: Sporadic ataxia (SA) is classified as a neurological condition characterized by adult onset,…
  • 2018 International Congress

    Open-label pilot trial of citicoline for fragile X-associated tremor/ataxia syndrome (FXTAS)

    D. Hall, E. Robertson, M. Leehey, A. McAsey, B. Ouyang, E. Berry-Kravis, J. O'Keefe (Chicago, IL, USA)

    Objective: To determine if citicoline was safe and effective for treatment of tremor and balance abnormalities and stabilization of cognitive decline in patients with FXTAS.…
  • 2018 International Congress

    Slowly progressive anti-Ca/ARHGAP26 autoantibody-associated cerebellar ataxia over 27 years without immunosuppressive treatment

    E. Schegk, I. Beiser, A. Wicki, L. Achtnichts, M. Bertschi (Aarau, Switzerland)

    Objective: To discuss a slowly progressive case of anti-Ca/ARHGAP26 autoantibody-associated cerebellar ataxia. Background: Anti-Ca/ARHGAP26 autoantibody-associated cerebellar ataxia was first identified in 2010 (1). Since then,…
  • 2018 International Congress

    Electrophysiological characteristics of tremor in spinocerebellar ataxia type12 (SCA-12) and essential tremor (ET)

    A. Srivastava, M. Narang, R. Rajan, G. Shukla, F. Mohammad, A. Pandit, D. Vibha, M. Singh, M. Srivastava, K. Prasad (New Delhi, India)

    Objective: The aim of the study was to describe electrophysiological features of tremor in SCA12 patients and to compare it with that in ET patients.…
  • 2018 International Congress

    Treatment with docosahexaenoic acid in Spinocerebellar Ataxia 38

    D. Perani, L. Orsi, C. Costanzi, M. Ferrero, A. Zoppo, F. Tempia, D. Caruso, M. Grassi, A. Padovani, A. Brusco, B. Borroni (Brescia, Italy)

    Objective: To evaluate the safety and efficacy of docosahexaenoic acid supplementation in patients with spinocerebellar ataxia 38 (SCA 38), on clinical symptoms and changes of…
  • 2018 International Congress

    mGluR1 antibodies encephalitis: A rare cause of reversible ataxia and myoclonus syndrome

    F. Ory Magne, C. Goillion, J. Dupouy, M. Simonetta, C. Brefel Courbon, O. Rascol, J. (Toulouse, France)

    Objective: We wanted to report the case of a patient with severe subacute cerebellar ataxia related to mGluR1-antibodies with a clear improvement after immunomodulator treatment.…
  • 2018 International Congress

    Clinical characteristics of a family harbouring a novel CCDC88C mutation (SCA40)

    W. Nachbauer, E. Indelicato, A. Eigentler, S. Boesch (Innsbruck, Austria)

    Objective: We here report on clinical features and course of disease in a novel CCDC88C mutation causing spinocerebellar ataxia type 40 (SCA40). Background: SCA40 is…
  • 2018 International Congress

    FXN and ATXN2 methylation profile in Friedreich’s ataxia and spinocerebellar ataxia type 2

    E. Nuzhnyi, N. Abramycheva, T. Pogoda, S. Klyushnikov, M. Ershova, S. Illarioshkin, E. Fedotova (Moscow, Russian Federation)

    Objective: To compare methylation profiles in frataxin (FXN) and ataxin-2 (ATXN2) genes in patients with spinocerebellar ataxia type 2 (SCA2), Friedreich’s ataxia (FA) and a…
  • 2018 International Congress

    Transcriptional profiling of peripheral blood monocytes from child Friedreich’s ataxia patient: New molecules and patterns of gene expression

    H. Singh, V. Swarup, R. Singh, I. Singh, M. Faruq, S. Vivekanandhan, A. Srivastava (Delhi, India)

    Objective: To explore peripheral biomarkers related to Friedreich's ataxia and identification of pathophysiological insights of complex phenotype Background: Friedreich's ataxia(FRDA) causes nervous system damage and…
  • « Previous Page
  • 1
  • …
  • 1257
  • 1258
  • 1259
  • 1260
  • 1261
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley